Completed × Urinary Bladder Neoplasms × Cisplatin × Clear all KEYNOTE-B15
Phase 3 Completed
808 enrolled
Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)
Phase 1/2 Completed
272 enrolled
Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer
Phase 2 Completed
17 enrolled 12 charts
KEYVIBE-005
Phase 2 Completed
613 enrolled
BLAST
Phase 1 Completed
22 enrolled
Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects
Phase 1/2 Completed
83 enrolled 14 charts
IMvigor130
Phase 3 Completed
1,213 enrolled 35 charts
PCR-MIB
Phase 2 Completed
28 enrolled 15 charts
Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer
Phase 2 Completed
37 enrolled 19 charts
COXEN
Phase 2 Completed
237 enrolled 20 charts
Gemcitabine, Cisplatin, Plus Nivolumab in Patients With Muscle-invasive Bladder Cancer With Selective Bladder Sparing
Phase 2 Completed
76 enrolled 14 charts
The Impact of Neoadjuvant Chemotherapy on Survival Outcomes in Patients With Variant Histologies Bladder Cancer Who Underwent Radical Cystectomy
Completed
221 enrolled
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors
Phase 1 Completed
71 enrolled
Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium
Phase 3 Completed
330 enrolled
Combination Chemotherapy in Treating Patients With Bladder Cancer
Phase 3 Completed
490 enrolled
Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer
Phase 2 Completed
2 enrolled 8 charts
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
Phase 2 Completed
70 enrolled 18 charts
BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy
Phase 2 Completed
43 enrolled 20 charts
Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases
Phase 2 Completed
6 enrolled
Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract
Phase 2 Completed
53 enrolled
Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer
Phase 2 Completed
51 enrolled 11 charts
Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
Phase 1 Completed
10 enrolled 14 charts
Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)
Phase 2 Completed
63 enrolled
Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium
Phase 2 Completed
71 enrolled
Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer
Phase 2 Completed
97 enrolled 8 charts
Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium
Phase 1/2 Completed
15 enrolled
Efficacy Study of Adding Chemotherapy to Radiotherapy for Treating Bladder Cancer.
Phase 3 Completed
67 enrolled
CVH-CT02
Phase 2 Completed
61 enrolled
Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
Phase 2 Completed
39 enrolled 7 charts
Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
Phase 3 Completed
285 enrolled
Combination Chemotherapy in Treating Patients With Bladder Cancer
Phase 3 Completed
42 enrolled
Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer
Phase 2 Completed
60 enrolled 10 charts
Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
Phase 2 Completed
18 enrolled 8 charts
GEMCIRAV
Phase 1/2 Completed
14 enrolled
Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer
Phase 1 Completed
18 enrolled
Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer
Phase 2 Completed
6 enrolled
Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer
Phase 2 Completed
37 enrolled
Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer
Phase 2 Completed
40 enrolled
Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer
Phase 2 Completed
30 enrolled
Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer
Phase 1/2 Completed
30 enrolled
Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer
Phase 1 Completed
30 enrolled
Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
Phase 3 Completed
608 enrolled
Neoadjuvant Chemotherapy in Locally Advanced Bladder Cancer
Phase NA Completed
60 enrolled
S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium
Phase 2 Completed
7 enrolled
Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium
Phase 2 Completed
65 enrolled
Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCT
Phase 2 Completed
125 enrolled
Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder Cancer
Phase 2 Completed
2 enrolled